PFE•benzinga•
Pfizer Discontinues Once-Daily Weight Loss Pill Over Liver Injury In One Patient
Summary
Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 14, 2025 by benzinga